Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells

Citation
H. Kouchi et al., Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells, BIOC BIOP R, 264(3), 1999, pp. 915-920
Citations number
26
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
264
Issue
3
Year of publication
1999
Pages
915 - 920
Database
ISI
SICI code
0006-291X(19991102)264:3<915:MAIORF>2.0.ZU;2-R
Abstract
Restenosis after angioplasty is thought to be caused by proliferation and m igration of vascular smooth muscle cells (VSMCs), and it is a most serious problem in medical treatment. A low dose (50 ng/ml) of manumycin A, an inhi bitor of p21(ras) (ras) farnesylation, significantly inhibited proliferatio n of rat VSMCs stimulated by the platelet-derived growth factor (PDGF). The mitoinhibitory effect of manumycin A was dose- and time-dependent but was independent of cell density. Western blot analysis showed that manumycin A reduced the amount of functional ras localized at the cytoplasmic membrane and inhibited the phosphorylation of p42/44 mitogen-activated protein kinas e (MAPK). Manumycin A also inhibited VSMC migration and disorganized alpha actin fibers, as shown by immnofluorecence staining. These results indicate that the interruption of the ras/MAPK signal transduction pathway and the disorganization of alpha actin fibers are the main cause of manumycin A inh ibition of VSMC proliferation and migration induced by PDGF. (C) 1999 Acade mic Press.